European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
“EORTC at European Society for Radiotherapy and Oncology (ESTRO) 2026
EORTC will have a strong scientific presence at ESTRO2026, with contributions spanning proffered papers, mini‑orals, posters, and digital posters. Results from clinical trials such as EORTC‑22922/10925 and prospective cohorts such as OligoCare will be presented, covering key areas including SBRT, re‑irradiation, RTQA, quality of life, and trial methodology.
Key contributions also include:
- a co‑led ESTRO–EORTC symposium on designing radiotherapy trials for future generations, and
- a contribution to a symposium session on the future of RTQA in clinical trials and beyond.
These contributions highlight the breadth of EORTC‑led and collaborative research shaping the future of cancer treatment.
Explore our full presence.”
